跳至主要内容
临床试验/NCT05911789
NCT05911789尚未招募1 期

A Prospective Study to Evaluate Online Adaptive Radiotherapy in Rectal Cancer

Peking Union Medical College Hospital0 个研究点目标入组 15 人开始时间: 2023年8月5日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
入组人数
15
主要终点
Response rate after surgery

研究概览

简要总结

In the present study, the investigators will evaluate the efficacy, toxicities, and of online adaptive radiation therapy (ART) for patients with rectal cancer treated with neoadjuvant chemoradiotherapy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥18 years old;
  • Diagnose with rectal cancer;
  • T3-T4 or N+, and no distant metastasis
  • Neoadjuvant chemoradiotherapy intended;
  • Surgery is expected after neoadjuvant therapy;
  • ECOG score 0-2, expected to lie in the treatment bed for at least half an hour;

排除标准

  • With contraindications to rectal MRI;
  • Received surgery, radiotherapy or chemotherapy for rectal cancer;
  • History of pelvic radiotherapy.

结局指标

主要结局

Response rate after surgery

时间窗: 3 monsh after treatment

Clinical and pathological complete response and partial response rate after chemoradiotherapy

Acute toxicities(CTCA

时间窗: 3 months for the start of treatment

evaluated with Common Terminology Criteria for Adverse Events (CTCAE) 5.0

次要结局

  • Dose coverage of target volume (assessed by planing target volume V100%)(Through study completion, an average of five month)
  • Chronic toxicity(2 years after treatment)
  • Margins for clinical target volume(CTV) and gross tumor volume (GTV)(Through study completion, an average of five month)

研究者

申办方类型
Other
责任方
Sponsor

相似试验